These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. A young patient with end-stage renal disease, dyspnoea, weakness, peripheral neuropathy and an unsuspected underlying disease. Wichmann G; Passauer J; Fischer R; Weise M; Gross P Nephrol Dial Transplant; 2003 Aug; 18(8):1670-2. PubMed ID: 12897114 [No Abstract] [Full Text] [Related]
64. Surgical interventions for nephrolithiasis in ankylosing spondylitis and the general population. Jakobsen AK; Jacobsson LTH; Patschan O; Hopfgarten T; Askling J; Kristensen LE Scand J Urol; 2015 Dec; 49(6):486-491. PubMed ID: 26389795 [TBL] [Abstract][Full Text] [Related]
65. Biochemical diagnosis in 3040 kidney stone formers in Argentina. Spivacow FR; del Valle EE; Negri AL; Fradinger E; Abib A; Rey P Urolithiasis; 2015 Aug; 43(4):323-30. PubMed ID: 25958053 [TBL] [Abstract][Full Text] [Related]
66. Primary and secondary hyperoxaluria: Understanding the enigma. Bhasin B; Ürekli HM; Atta MG World J Nephrol; 2015 May; 4(2):235-44. PubMed ID: 25949937 [TBL] [Abstract][Full Text] [Related]
67. Navigating the Evolving Landscape of Primary Hyperoxaluria: Traditional Management Defied by the Rise of Novel Molecular Drugs. Huang Y; Zhu W; Zhou J; Huang Q; Zeng G Biomolecules; 2024 Apr; 14(5):. PubMed ID: 38785918 [TBL] [Abstract][Full Text] [Related]
68. GC-MS based metabolite profiling, antioxidant and antiurolithiatic properties of apple cider vinegar. Singh AS; Singh A; Vellapandian C; Ramaswamy R; Thirumal M Future Sci OA; 2023 Apr; 9(4):FSO855. PubMed ID: 37090488 [TBL] [Abstract][Full Text] [Related]
72. Structural and chemical heterogeneities of primary hyperoxaluria kidney stones from pediatric patients. Du Y; Roger VB; Mena J; Kang M; Stoller ML; Ho SP J Pediatr Urol; 2021 Apr; 17(2):214.e1-214.e11. PubMed ID: 33495102 [TBL] [Abstract][Full Text] [Related]
73. Recent advances in the identification and management of inherited hyperoxalurias. Sas DJ; Harris PC; Milliner DS Urolithiasis; 2019 Feb; 47(1):79-89. PubMed ID: 30535828 [TBL] [Abstract][Full Text] [Related]
74. Molecular basis of primary hyperoxaluria: clues to innovative treatments. Dindo M; Conter C; Oppici E; Ceccarelli V; Marinucci L; Cellini B Urolithiasis; 2019 Feb; 47(1):67-78. PubMed ID: 30430197 [TBL] [Abstract][Full Text] [Related]
75. Treatment of renal stones in children: a comparison between percutaneous nephrolithotomy and shock wave lithotripsy. Shokeir AA; Sheir KZ; El-Nahas AR; El-Assmy AM; Eassa W; El-Kappany HA J Urol; 2006 Aug; 176(2):706-10. PubMed ID: 16813924 [TBL] [Abstract][Full Text] [Related]
76. Simultaneous combined use of flexible ureteroscopy and percutaneous nephrolithotomy to reduce the number of access tracts in the management of complex renal calculi. Marguet CG; Springhart WP; Tan YH; Patel A; Undre S; Albala DM; Preminger GM BJU Int; 2005 Nov; 96(7):1097-100. PubMed ID: 16225535 [TBL] [Abstract][Full Text] [Related]
77. Percutaneous treatment of large upper tract stones after urinary diversion. el-Nahas AR; Eraky I; el-Assmy AM; Shoma AM; el-Kenawy MR; Abdel-Latif M; Mosbah A; Abol-Enein H; Shaaban AA; Mohsen T; el-Kappany HA Urology; 2006 Sep; 68(3):500-4. PubMed ID: 16979745 [TBL] [Abstract][Full Text] [Related]